TFS International, a leading, mid-sized clinical Contract Research Organization (CRO) is dedicated to the innovative use of technology to advance clinical development.
TFS contributed to this success through its collaboration with Lobsor Pharmaceuticals AB under a risk-sharing partnership, performing the regulatory strategy, clinical development planning and execution and Marketing Authorization (MA) filing.
TFS contributed to this success through its collaboration with Lobsor Pharmaceuticals AB under a risk-sharing partnership, performing the regulatory strategy, clinical development planning and execution and Marketing Authorization (MA) filing.
TFS International is delighted to announce that Dr Suzanne Pavon has accepted the position of Executive Vice President, Quality Assurance. Dr Pavon is an entrepreneurial